INTRAVESICAL CHEMOTHERAPY AND IMMUNOTHERAPY: HOW DO WE ASSESS THEIR EFFECTIVENESS AND WHAT ARE THEIR LIMITATIONS AND USES?
- 1 June 1995
- journal article
- Published by Wiley in International Journal of Urology
- Vol. 2 (s2) , 23-35
- https://doi.org/10.1111/j.1442-2042.1995.tb00476.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- LONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCERUrologic Clinics of North America, 1992
- Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese urological cancer research group for AdriamycinCancer Chemotherapy and Pharmacology, 1992
- Prophylactic Effect of aLactobacillus caseiPreparation on the Recurrence of Superficial Bladder CancerUrologia Internationalis, 1992
- Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.Journal of Clinical Oncology, 1988
- An Overview of Intravesical Therapy for Superficial Bladder TumorsJournal of Urology, 1987
- Bacillus Calmette-Guerin Immunotherapy for Bladder CancerJournal of Urology, 1985
- Mode of Presentation of Invasive Bladder Cancer: Reassessment of the ProblemJournal of Urology, 1982
- Management of Carcinoma In Situ of the Bladder: The Case for Surgical ManagementUrologic Clinics of North America, 1980
- Flat Carcinoma in situ of BladderBritish Journal of Urology, 1975
- Benign Papilloma or Papillary Carcinoma of the Bladder?Journal of Urology, 1973